Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concordance of symptoms perceived by patients receiving haemodialysis and those reported by nurses and nephrologists: a cross-sectional, multicentre, observational study using the REIN registry.
Guerraoui A, Haesebaert J, Subtil F, Hanf W, Pelletier C, Jullien P, Villar E, Mezaache S, Filancia A, Fauvel JP, Mariat C, Granal M, Guebre-Egziabher F, Couchoud C, Caillette-Beaudoin A, Fouque D. Guerraoui A, et al. Among authors: guebre egziabher f. Clin Kidney J. 2025 Jul 30;18(9):sfaf239. doi: 10.1093/ckj/sfaf239. eCollection 2025 Sep. Clin Kidney J. 2025. PMID: 40927381 Free PMC article.
Chronic kidney disease-associated pruritus: a comparison of instruments and associations with patient-reported outcomes using an electronic patient-reported outcome survey in Europe.
Guedes M, Tu C, Sukul N, Asgari E, Guebre-Egziabher F, Ruessmann D, Schaufler T, Rayner H, Jadoul M, Labriola L, Pecoits-Filho R, Pisoni RL, Karaboyas A. Guedes M, et al. Among authors: guebre egziabher f. Clin Kidney J. 2024 Sep 4;17(10):sfae276. doi: 10.1093/ckj/sfae276. eCollection 2024 Oct. Clin Kidney J. 2024. PMID: 39669400 Free PMC article.
Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial.
Sellier-Leclerc AL, Magen D, Shasha-Lavsky H, Simkova E, Devresse A, Guebre-Egziabher F, Michael M, Lieske JC, Frishberg Y, Bakkaloglu SA, Mourani C, Saqan R, Singer R, Guzzo I, Makarova N, Willey R, Kaspar C, Gansner JM, Groothoff JW. Sellier-Leclerc AL, et al. Among authors: guebre egziabher f. Am J Kidney Dis. 2025 Aug;86(2):285-288. doi: 10.1053/j.ajkd.2025.01.016. Epub 2025 Mar 13. Am J Kidney Dis. 2025. PMID: 40086686 No abstract available.
[Intradialytic parenteral nutrition: theory and practical application].
Pasian C, Azar R, Fouque D, Koppe L, Guebre-Egziabher F, Valla FV, Trolonge S, Chauveau P, Nodimar C, Brien L, Bataille S. Pasian C, et al. Among authors: guebre egziabher f. Nephrol Ther. 2025 May 15;21(2):73-87. doi: 10.1684/ndt.2025.117. Nephrol Ther. 2025. PMID: 40372263 French.
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.
Bohula EA, Marston NA, Bhatia AK, De Ferrari GM, Leiter LA, Nicolau JC, Park JG, Kuder JF, Murphy SA, Walsh E, Wang H, Blaha V, Budaj A, Cornel JH, Goudev A, Kiss RG, Lorenzatti AJ, Parkhomenko A, Cyrille M, Paiva da Silva Lima G, Ohman EM, Giugliano RP, Sabatine MS; VESALIUS-CV Investigators. Bohula EA, et al. N Engl J Med. 2026 Jan 8;394(2):117-127. doi: 10.1056/NEJMoa2514428. Epub 2025 Nov 8. N Engl J Med. 2026. PMID: 41211925 Clinical Trial.
97 results